Athanassios I. Philippopoulos

Electrochemical studies of the bis (triphenyl phosphine) ruthenium(II) complex, cis -[RuCl2(L)(PPh3)2], with L = 2-(2′-pyridyl)quinoxaline

Electrochemical studies of the newly synthesized bis(triphenyl phosphine) ruthenium(II) complex, cis-[RuCl2(L)(PPh3)2] (1, with L = 2-(2′-pyridyl)quinoxaline, C13N3H9), were performed in acetonitrile (ACN). For this purpose, cyclic voltammograms (CVs) as well as electrochemical impedance spectra (EIS) were recorded on either glassy carbon (GC), platinum (Pt), gold (Au), or multi-walled carbon nanotube (MWCNT) electrodes. Qualitative examination of solutions of 1 in ACN was performed on the basis of conductivity measurements and electrospray ionization mass spectrometry (ESI–MS). The conductivity data suggest that 1 is a 1 : 1 type electrolyte in ACN. The ESI spectra further demonstrate that upon dissolution of 1 in ACN progressive replacement of chloro- and PPh3-ligands by ACN occurs, leading to formation of [RuCl(L)(PPh3)(CH3CN)2]+Cl−, [2 + Cl − ]. The CVs recorded for [2 + Cl − ] on various working electrodes demonstrate that the reversibility of the redox couple 22 +/+ enhances with the order: Au < Pt < MWCNT < GC. The EI spectra verify that GC and MWCNT electrodes provide insignificant barrier for interfacial electron transfer since they afford less charge-transfer resistance.

A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?

In this minireview, we refer to recent results as far as the Platelet Activating Factor (PAF) inhibitors are concerned. At first, results of organic compounds (natural and synthetic ones and specific and nonspecific) as inhibitors of PAF are reported. Emphasis is given on recent results about a new class of the so-called metal-based inhibitors of PAF. A small library of 30 metal complexes has been thus created; their anti-inflammatory activity has been further evaluated owing to their inhibitory effect against PAF in washed rabbit platelets (WRPs). In addition, emphasis has also been placed on the identification of preliminary structure-activity relationships for the different classes of metal-based inhibitors.

Synthesis and spectroscopic characterization of new heteroleptic ruthenium(II) complexes incorporating 2-(2′-pyridyl)quinoxaline and 4-carboxy-2-(2′-pyridyl)quinoline

Starting from cis-[Ru(dcbpyH2)2Cl2] (1), two new heteroleptic ruthenium(II) complexes, [Ru(dcbpyH2)2(L1)](NO3)2 (L1 = 2-(2′-pyridyl)quinoxaline (2), and [Ru(dcbpyH2)2(L2)](NO3)2 (L2 = 4-carboxy-2-(2′-pyridyl)quinoline (4); dcbpyH2 = 2,2′-bipyridine-4,4′-dicarboxylic acid), were synthesized and spectroscopically characterized. During the preparation of 2 and 4, the homoleptic [Ru(dcbpyH2)3]Cl2 complex (3) was isolated as a side product. Characterization includes IR and Raman spectroscopy, UV-Vis, multinuclear NMR spectroscopy, elemental, and ESI-mass spectrometric analyses.

Inorganic tin compounds do not induce micronuclei in human lymphocytes in the absence of metabolic activation

Abstract The genotoxic evaluation (in vitro analysis) of a series of eight inorganic tin(II) and tin(IV) compounds [tin(II) acetate, tin(II) chloride, tin(II) ethylhexanoate, tin(II) oxalate, tin(II) oxide, tin(IV) acetate, tin(IV) chloride and tin(IV) oxide], for the detection of micronuclei in human blood lymphocytes, was performed in the absence of metabolic activation by the cytokinesis-block micronucleus assay. Human lymphocytes were treated for over one cell cycle (31 hours), with concentrations ranging from 1 to 75 μM (1, 5, 10, 20, 50 and 75 μM), of tin(II) and tin(IV) salts dissolved in dimethyl sulfoxide. The above-listed concentrations cover the values that have been detected in humans with no occupational exposure to tin compounds. The experimental results show the absence of genotoxicity for all inorganic compounds tested in the specific concentrations and experimental conditions. Cytotoxic effects of tin(II) and tin(IV) compounds were evaluated by the determination of cytokinesis block proliferation index and cytotoxicity percentage. Our observations on the cytotoxicity pattern of the tested tin(II) and tin(IV) compounds indicate that they are cytotoxic in several tested concentrations to human lymphocytes treated in vitro. The observed differences in cytotoxicity of each tested compound might reflect differences in their chemical structure.